Multiply Labs today announced an agreement with AstraZeneca to evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing. Multiply Labs is a current ...
SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, today announced its upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results